(2000). HMG-CoA reductase inhibitors and the risk of fractures. Jama.
. M. Kraenzlin
First name
M.
Middle name
E.
Last name
Kraenzlin
(2004). Use of beta-blockers and risk of fractures. Jama. http://doi.org/10.1001/jama.292.11.1326
. (2008). Use of thiazolidinediones and fracture risk. Arch Intern Med. http://doi.org/10.1001/archinte.168.8.820
. (2010). Use of depot medroxyprogesterone acetate and fracture risk. J Clin Endocrinol Metab. http://doi.org/10.1210/jc.2010-0032
.